Search Results

US. Sues to Block Amgen's $2Z8 Billion Takeover of Horizon.

• Authors : ROBBINS, REBECCA; McCabe, David

Subjects: AMGEN Inc.; MERGERS & acquisitions; PHARMACEUTICAL industry

• Source: New York Times. 5/17/2023, Vol. 172 Issue 59791, pB5-B5. 1/7p.

Record details

AMGEN SAYS PARKINSON'S TREATMENT FAILED IN STUDY.

Subjects: AMGEN Inc.; PARKINSON'S disease treatment; CLINICAL drug trials

• Source: New York Times. 6/29/2004, Vol. 153 Issue 52895, pC5-C5. 999p.

Record details

Ready for the Admiral.

• Authors : Rifkin, Glenn

Subjects: SHARER, Kevin W.; AMGEN Inc.; EXECUTIVES

• Source: New York Times. 6/20/2004, Vol. 153 Issue 52886, Sunday Business p10-10. 999p. 1 Black and White Photograph.

Record details

Amgen Buys Producer Of Drugs For Cancer.

• Authors : POLLACK, ANDREW (AUTHOR); de la MERCED, MICHAEL J. (AUTHOR)

Subjects: *PHARMACEUTICAL industry mergers; *CANCER treatment; *HEALTH care industryAMGEN Inc. 039976196 AMGEN Inc. AMGEN Inc. 039976196 039976196 AMGEN Inc. 039976196 AMGN; ONYX Pharmaceuticals Inc. 789591724 ONYX Pharmaceuticals Inc. ONYX Pharmaceuticals Inc. 789591724 789591724 ONYX Pharmaceuticals Inc. 789591724 ONXX

• Source: New York Times. 8/26/2013, Vol. 162 Issue 56240, pB1-B6. 2p.

Record details

Fiscal Footnote: Big Senate Gift To Drug Maker.

• Authors : LIPTON, ERIC (AUTHOR); SACK, KEVIN (AUTHOR)

Subjects: *LOBBYING; *HEMODIALYSIS; *MEDICAREUNITED StatesAMGEN Inc. 039976196 AMGEN Inc. AMGEN Inc. 039976196 039976196 AMGEN Inc. 039976196 AMGN

• Source: New York Times. 1/20/2013, Vol. 162 Issue 56022, pA1-A4. 2p. 2 Black and White Photographs.

Record details

Duel Over a Monopoly.

• Authors : Pollack, Andrew

Subjects: *PHARMACEUTICAL industry & economics; *PATENT suits; *ANEMIA treatmentAMGEN Inc. 039976196 AMGEN Inc. AMGEN Inc. 039976196 039976196 AMGEN Inc. 039976196 AMGN; F. Hoffmann-La Roche Ltd.

• Source: New York Times. 10/17/2007, Vol. 157 Issue 54100, pC1-C4. 2p. 1 Color Photograph, 1 Black and White Photograph, 1 Chart.

Record details

Amgen Seeks To Reverse Its Bad News.

• Authors : Pollack, Andrew

Subjects: *BUSINESS failures; *BIOTECHNOLOGY industries; *MISMANAGEMENTUNITED StatesAMGEN Inc. 039976196 AMGEN Inc. AMGEN Inc. 039976196 039976196 AMGEN Inc. 039976196 AMGN; UNITED States. Food & Drug Administration

• Source: New York Times. 4/17/2007, Vol. 156 Issue 53917, pC1-C6. 2p.

Record details

Panel Tells F.D.A. to Back Second Drug to Help Heart.

• Authors : KOLATA, GINA

Subjects: AMGEN Inc.; UNITED States. Food & Drug Administration

• Source: New York Times. 6/11/2015, Vol. 164 Issue 56894, pA15-A15. 1/4p.

Record details

BUSINESS BRIEFING.

Subjects: AMGEN Inc.; UNITED States. Internal Revenue Service; LABOR marketUNITED States

• Source: New York Times. 4/23/2014, Vol. 163 Issue 56480, pB2-B2. 1/6p.

Record details

BUSINESS BRIEFING.

Subjects: AMGEN Inc.; 30 Saint Mary Axe (London, England); CORNING Inc.

• Source: New York Times. 7/30/2014, Vol. 163 Issue 56578, pB2-B2. 1/9p.

Record details